skip to Main Content

“At a time of rapid therapeutic innovation in blood cancers, new trial delivery models such as ACT are urgently needed. I am impressed with ACT’s delivery to work with world class laboratories to deliver a truly transformative clinical trials proposition at pace”

Prof Paresh Vyas
Professor of Haematology at Oxford University